Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Improved method for vWF purification developed by Bayer

Dec. 31, 1997

DX-9065a exhibits antithrombotic efficacy and no effects on hemostasis in animal model

Dec. 29, 1997

Tanabe Seiyaku claims new PAI-1 inhibitors

Dec. 24, 1997

FDA issues health advisory for anticoagulants

Dec. 18, 1997

Promising results reported from rhATIII trial

Dec. 18, 1997

Boehringer Mannheim describes antiplatelet agents

Dec. 18, 1997

Phase II trial of Vasoflux begins in acute MI

Dec. 17, 1997

Cytoprotective effects of TTC-909 demonstrated in SHR-SP

Dec. 15, 1997

Integrilin to be reviewed by FDA advisory panel

Dec. 11, 1997

New indication for Neutralase revealed

Dec. 11, 1997

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...